Entera Bio Ltd.
Entera Bio Ltd. (ENTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
entx · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.20
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.18 | ↓ 1.57% |
1-day model range: $1.17–$1.19. Peak: $1.19 (-1.57%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -37.0% |
| 2028 | $1 | -48.7% |
| 2029 | $1 | -53.5% |
| 2030 | $1 | -55.6% |
| 2031 | — | -56.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ENTX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-09-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Entera Bio Ltd. (ENTX) stock. Of the recent 22 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover ENTX.
Analyst Recommendation Trends
ENTX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↑ 35.7% YoY
Revenue Next Year
$0M
↑ 143.9% YoY
EPS This Year
$-0.26
EPS Next Year
$-0.28
↑ 8.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast ENTX EPS of $-0.26 for the current fiscal year, based on estimates from 1 analysts. The ENTX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ENTX stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ENTX price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The ENTX short-term stock prediction for tomorrow is $1.18 (-1.57%). The ENTX stock price prediction for 2027 estimates an average of $1. The ENTX stock prediction for 2030 projects a range of $0–$1.
Entera Bio Ltd. trades on NASDAQ under the ticker ENTX. The ENTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
ENTX forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month ENTX price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.20.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.